Immunicon's cell counting tech predicts breast cancer prognosis
This article was originally published in Clinica
Executive Summary
A breast cancer test that counts circulating tumour cells (CTCs) in blood can help predict a patient's response to therapy faster and more reliably than current methods, a major US study has shown.